2.4.0.8 Html 170 328 1 false 46 0 false 7 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.meridianbioscience.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information false false R2.htm 103 - Statement - Consolidated Statements of Operations Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfIncome Consolidated Statements of Operations false false R3.htm 104 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfOtherComprehensiveIncome Consolidated Statements of Comprehensive Income false false R4.htm 105 - Statement - Consolidated Statements of Cash Flows Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows true false R5.htm 106 - Statement - Consolidated Balance Sheets Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets false false R6.htm 107 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Consolidated Balance Sheets (Parenthetical) false false R7.htm 108 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Consolidated Statements of Shareholders' Equity false false R8.htm 109 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical) Sheet http://www.meridianbioscience.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical Consolidated Statements of Shareholders' Equity (Parenthetical) false false R9.htm 110 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies false false R10.htm 111 - Disclosure - Inventories Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventories false false R11.htm 112 - Disclosure - Bank Credit Arrangements Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Bank Credit Arrangements false false R12.htm 113 - Disclosure - Fair Value Measurements Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements false false R13.htm 114 - Disclosure - Income Taxes Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes false false R14.htm 115 - Disclosure - Employee Benefits Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Employee Benefits false false R15.htm 116 - Disclosure - Reportable Segment and Major Concentrations Data Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Reportable Segment and Major Concentrations Data false false R16.htm 117 - Disclosure - Commitments and Contingencies Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies false false R17.htm 118 - Disclosure - Quarterly Financial Data Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock Quarterly Financial Data false false R18.htm 119 - Disclosure - Subsequent Events Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events false false R19.htm 120 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) false false R20.htm 121 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables Summary of Significant Accounting Policies (Tables) false false R21.htm 122 - Disclosure - Inventories (Tables) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventories (Tables) false false R22.htm 123 - Disclosure - Income Taxes (Tables) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables Income Taxes (Tables) false false R23.htm 124 - Disclosure - Employee Benefits (Tables) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Employee Benefits (Tables) false false R24.htm 125 - Disclosure - Reportable Segment and Major Concentrations Data (Tables) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables Reportable Segment and Major Concentrations Data (Tables) false false R25.htm 126 - Disclosure - Quarterly Financial Data (Tables) Sheet http://www.meridianbioscience.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables Quarterly Financial Data (Tables) false false R26.htm 127 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation Summary of Significant Accounting Policies - Additional Information (Detail) false false R27.htm 128 - Disclosure - Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Investments (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndInvestments Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Investments (Detail) false false R28.htm 129 - Disclosure - Summary of Significant Accounting Policies - Summary of Acquired Intangible Assets Subject to Amortization (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfAcquiredIntangibleAssetsSubjectToAmortization Summary of Significant Accounting Policies - Summary of Acquired Intangible Assets Subject to Amortization (Detail) false false R29.htm 130 - Disclosure - Inventories - Components of the Inventories (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureInventoriesComponentsOfTheInventories Inventories - Components of the Inventories (Detail) false false R30.htm 131 - Disclosure - Bank Credit Arrangements - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureBankCreditArrangementsAdditionalInformation Bank Credit Arrangements - Additional Information (Detail) false false R31.htm 132 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformation Fair Value Measurements - Additional Information (Detail) false false R32.htm 133 - Disclosure - Income Taxes - Earnings Before Income Taxes and Related Provision for Income Taxes (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureIncomeTaxesEarningsBeforeIncomeTaxesAndRelatedProvisionForIncomeTaxes Income Taxes - Earnings Before Income Taxes and Related Provision for Income Taxes (Detail) false false R33.htm 134 - Disclosure - Income Taxes - Reconciliation Between the Statutory U.S. Income Tax Rate and Effective Rate Derived by Dividing the Provision for Income Taxes by Earnings Before Income Taxes (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureIncomeTaxesReconciliationBetweenTheStatutoryUSIncomeTaxRateAndEffectiveRateDerivedByDividingTheProvisionForIncomeTaxesByEarningsBeforeIncomeTaxes Income Taxes - Reconciliation Between the Statutory U.S. Income Tax Rate and Effective Rate Derived by Dividing the Provision for Income Taxes by Earnings Before Income Taxes (Detail) false false R34.htm 135 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssets Income Taxes - Components of Net Deferred Tax Assets (Detail) false false R35.htm 136 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) false false R36.htm 137 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureIncomeTaxesUnrecognizedTaxBenefits Income Taxes - Unrecognized Tax Benefits (Detail) false false R37.htm 138 - Disclosure - Employee Benefits - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformation Employee Benefits - Additional Information (Detail) false false R38.htm 139 - Disclosure - Employee Benefits - Black-Scholes Option Pricing Model to Determine Grant-date Fair Value for Stock Options (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureEmployeeBenefitsBlackScholesOptionPricingModelToDetermineGrantdateFairValueForStockOptions Employee Benefits - Black-Scholes Option Pricing Model to Determine Grant-date Fair Value for Stock Options (Detail) false false R39.htm 140 - Disclosure - Employee Benefits - Summary of Stock Option Plans (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureEmployeeBenefitsSummaryOfStockOptionPlans Employee Benefits - Summary of Stock Option Plans (Detail) false false R40.htm 141 - Disclosure - Employee Benefits - Summary of Nonvested Options (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureEmployeeBenefitsSummaryOfNonvestedOptions Employee Benefits - Summary of Nonvested Options (Detail) false false R41.htm 142 - Disclosure - Reportable Segment and Major Concentrations Data - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureReportableSegmentAndMajorConcentrationsDataAdditionalInformation Reportable Segment and Major Concentrations Data - Additional Information (Detail) false false R42.htm 143 - Disclosure - Reportable Segment and Major Concentrations Data - Consolidated Net Sales (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureReportableSegmentAndMajorConcentrationsDataConsolidatedNetSales Reportable Segment and Major Concentrations Data - Consolidated Net Sales (Detail) false false R43.htm 144 - Disclosure - Reportable Segment and Major Concentrations Data - Significant Sales Information by Country for the Diagnostics and Life Science Reportable Segments (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureReportableSegmentAndMajorConcentrationsDataSignificantSalesInformationByCountryForTheDiagnosticsAndLifeScienceReportableSegments Reportable Segment and Major Concentrations Data - Significant Sales Information by Country for the Diagnostics and Life Science Reportable Segments (Detail) false false R44.htm 145 - Disclosure - Reportable Segment and Major Concentrations Data - Segment Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureReportableSegmentAndMajorConcentrationsDataSegmentInformation Reportable Segment and Major Concentrations Data - Segment Information (Detail) false false R45.htm 146 - Disclosure - Reportable Segment and Major Concentrations Data - Segment Information (Parenthetical) (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureReportableSegmentAndMajorConcentrationsDataSegmentInformationParenthetical Reportable Segment and Major Concentrations Data - Segment Information (Parenthetical) (Detail) false false R46.htm 147 - Disclosure - Reportable Segment and Major Concentrations Data - Pre-tax Earnings Table (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureReportableSegmentAndMajorConcentrationsDataPretaxEarningsTable Reportable Segment and Major Concentrations Data - Pre-tax Earnings Table (Detail) false false R47.htm 148 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) false false R48.htm 149 - Disclosure - Quarterly Financial Data - Summary of Quarterly Financial Data (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureQuarterlyFinancialDataSummaryOfQuarterlyFinancialData Quarterly Financial Data - Summary of Quarterly Financial Data (Detail) false false R49.htm 150 - Disclosure - Quarterly Financial Data - Summary of Quarterly Financial Data (Parenthetical) (Detail) Sheet http://www.meridianbioscience.com/taxonomy/role/DisclosureQuarterlyFinancialDataSummaryOfQuarterlyFinancialDataParenthetical Quarterly Financial Data - Summary of Quarterly Financial Data (Parenthetical) (Detail) false false All Reports Book All Reports 'Shares' elements on report '138 - Disclosure - Employee Benefits - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Consolidated Statements of Operations Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: 104 - Statement - Consolidated Statements of Comprehensive Income Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: 105 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 106 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: 107 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 109 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical) Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' vivo-20130930.xml vivo-20130930.xsd vivo-20130930_cal.xml vivo-20130930_def.xml vivo-20130930_lab.xml vivo-20130930_pre.xml true true